Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2
10.1038/ni.1606
Crossref journal-article
Springer Science and Business Media LLC
Nature Immunology (297)
Bibliography

Kawagoe, T., Sato, S., Matsushita, K., Kato, H., Matsui, K., Kumagai, Y., Saitoh, T., Kawai, T., Takeuchi, O., & Akira, S. (2008). Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2. Nature Immunology, 9(6), 684–691.

Authors 10
  1. Tatsukata Kawagoe (first)
  2. Shintaro Sato (additional)
  3. Kazufumi Matsushita (additional)
  4. Hiroki Kato (additional)
  5. Kosuke Matsui (additional)
  6. Yutaro Kumagai (additional)
  7. Tatsuya Saitoh (additional)
  8. Taro Kawai (additional)
  9. Osamu Takeuchi (additional)
  10. Shizuo Akira (additional)
References 48 Referenced 351
  1. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006). (10.1016/j.cell.2006.02.015) / Cell by S Akira (2006)
  2. Janeway, C.A., Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197–216 (2002). (10.1146/annurev.immunol.20.083001.084359) / Annu. Rev. Immunol. by CA Janeway Jr. (2002)
  3. Beutler, B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 257–263 (2004). (10.1038/nature02761) / Nature by B Beutler (2004)
  4. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143–150 (1998). (10.1016/S1074-7613(00)80596-8) / Immunity by O Adachi (1998)
  5. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115–122 (1999). (10.1016/S1074-7613(00)80086-2) / Immunity by T Kawai (1999)
  6. Fitzgerald, K.A. et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78–83 (2001). (10.1038/35092578) / Nature by KA Fitzgerald (2001)
  7. Horng, T., Barton, G.M. & Medzhitov, R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2, 835–841 (2001). (10.1038/ni0901-835) / Nat. Immunol. by T Horng (2001)
  8. Horng, T., Barton, G.M., Flavell, R.A. & Medzhitov, R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420, 329–333 (2002). (10.1038/nature01180) / Nature by T Horng (2002)
  9. Yamamoto, M. et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420, 324–329 (2002). (10.1038/nature01182) / Nature by M Yamamoto (2002)
  10. Hoebe, K. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424, 743–748 (2003). (10.1038/nature01889) / Nature by K Hoebe (2003)
  11. Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T. & Seya, T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4, 161–167 (2003). (10.1038/ni886) / Nat. Immunol. by H Oshiumi (2003)
  12. Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640–643 (2003). (10.1126/science.1087262) / Science by M Yamamoto (2003)
  13. Kagan, J.C. et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat. Immunol. 9, 361–368 (2008). (10.1038/ni1569) / Nat. Immunol. by JC Kagan (2008)
  14. Fitzgerald, K.A. et al. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198, 1043–1055 (2003). (10.1084/jem.20031023) / J. Exp. Med. by KA Fitzgerald (2003)
  15. Yamamoto, M. et al. TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway. Nat. Immunol. 4, 1144–1150 (2003). (10.1038/ni986) / Nat. Immunol. by M Yamamoto (2003)
  16. Janssens, S. & Beyaert, R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11, 293–302 (2003). (10.1016/S1097-2765(03)00053-4) / Mol. Cell by S Janssens (2003)
  17. Suzuki, N. et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416, 750–756 (2002). (10.1038/nature736) / Nature by N Suzuki (2002)
  18. Suzuki, N. et al. IL-1R-associated kinase 4 is required for lipopolysaccharide-induced activation of APC. J. Immunol. 171, 6065–6071 (2003). (10.4049/jimmunol.171.11.6065) / J. Immunol. by N Suzuki (2003)
  19. Honda, K. et al. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 101, 15416–15421 (2004). (10.1073/pnas.0406933101) / Proc. Natl. Acad. Sci. USA by K Honda (2004)
  20. Koziczak-Holbro, M. et al. IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression. J. Biol. Chem. 282, 13552–13560 (2007). (10.1074/jbc.M700548200) / J. Biol. Chem. by M Koziczak-Holbro (2007)
  21. Kim, T.W. et al. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 204, 1025–1036 (2007). (10.1084/jem.20061825) / J. Exp. Med. by TW Kim (2007)
  22. Kawagoe, T. et al. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling. J. Exp. Med. 204, 1013–1024 (2007). (10.1084/jem.20061523) / J. Exp. Med. by T Kawagoe (2007)
  23. Picard, C. et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299, 2076–2079 (2003). (10.1126/science.1081902) / Science by C Picard (2003)
  24. Medvedev, A.E. et al. Cutting edge: expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters normal IRAK-4 interaction with components of the IL-1 receptor complex. J. Immunol. 174, 6587–6591 (2005). (10.4049/jimmunol.174.11.6587) / J. Immunol. by AE Medvedev (2005)
  25. Yang, K. et al. Human TLR-7-, -8-, and -9-mediated induction of IFN-α/β and -λ is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 23, 465–478 (2005). (10.1016/j.immuni.2005.09.016) / Immunity by K Yang (2005)
  26. Ku, C.L. et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204, 2407–2422 (2007). (10.1084/jem.20070628) / J. Exp. Med. by CL Ku (2007)
  27. Kobayashi, K. et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191–202 (2002). (10.1016/S0092-8674(02)00827-9) / Cell by K Kobayashi (2002)
  28. Croston, G.E., Cao, Z. & Goeddel, D.V. NF-κB activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity. J. Biol. Chem. 270, 16514–16517 (1995). (10.1074/jbc.270.28.16514) / J. Biol. Chem. by GE Croston (1995)
  29. Kanakaraj, P. et al. Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J. Exp. Med. 187, 2073–2079 (1998). (10.1084/jem.187.12.2073) / J. Exp. Med. by P Kanakaraj (1998)
  30. Thomas, J.A. et al. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J. Immunol. 163, 978–984 (1999). (10.4049/jimmunol.163.2.978) / J. Immunol. by JA Thomas (1999)
  31. Uematsu, S. et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction. J. Exp. Med. 201, 915–923 (2005). (10.1084/jem.20042372) / J. Exp. Med. by S Uematsu (2005)
  32. Muzio, M., Ni, J., Feng, P. & Dixit, V.M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612–1615 (1997). (10.1126/science.278.5343.1612) / Science by M Muzio (1997)
  33. Hardy, M.P. & O'Neill, L.A. The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. J. Biol. Chem. 279, 27699–27708 (2004). (10.1074/jbc.M403068200) / J. Biol. Chem. by MP Hardy (2004)
  34. Keating, S.E., Maloney, G.M., Moran, E.M. & Bowie, A.G. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFκB via activation of TRAF6 ubiquitination. J. Biol. Chem. 282, 33435–33443 (2007). (10.1074/jbc.M705266200) / J. Biol. Chem. by SE Keating (2007)
  35. Wesche, H. et al. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J. Biol. Chem. 274, 19403–19410 (1999). (10.1074/jbc.274.27.19403) / J. Biol. Chem. by H Wesche (1999)
  36. Yamin, T.T. & Miller, D.K. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272, 21540–21547 (1997). (10.1074/jbc.272.34.21540) / J. Biol. Chem. by TT Yamin (1997)
  37. Li, X. et al. Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. Mol. Cell. Biol. 19, 4643–4652 (1999). (10.1128/MCB.19.7.4643) / Mol. Cell. Biol. by X Li (1999)
  38. Swantek, J.L., Tsen, M.F., Cobb, M.H. & Thomas, J.A. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164, 4301–4306 (2000). (10.4049/jimmunol.164.8.4301) / J. Immunol. by JL Swantek (2000)
  39. Li, S., Strelow, A., Fontana, E.J. & Wesche, H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA 99, 5567–5572 (2002). (10.1073/pnas.082100399) / Proc. Natl. Acad. Sci. USA by S Li (2002)
  40. Knop, J. & Martin, M.U. Effects of IL-1 receptor-associated kinase (IRAK) expression on IL-1 signaling are independent of its kinase activity. FEBS Lett. 448, 81–85 (1999). (10.1016/S0014-5793(99)00322-1) / FEBS Lett. by J Knop (1999)
  41. Maschera, B., Ray, K., Burns, K. & Volpe, F. Overexpression of an enzymically inactive interleukin-1-receptor-associated kinase activates nuclear factor-κB. Biochem. J. 339, 227–231 (1999). (10.1042/bj3390227) / Biochem. J. by B Maschera (1999)
  42. Li, X., Commane, M., Jiang, Z. & Stark, G.R. IL-1-induced NFκB and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proc. Natl. Acad. Sci. USA 98, 4461–4465 (2001). (10.1073/pnas.071054198) / Proc. Natl. Acad. Sci. USA by X Li (2001)
  43. Jensen, L.E. & Whitehead, A.S. IRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability. J. Biol. Chem. 276, 29037–29044 (2001). (10.1074/jbc.M103815200) / J. Biol. Chem. by LE Jensen (2001)
  44. Rechsteiner, M. & Rogers, S.W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21, 267–271 (1996). (10.1016/S0968-0004(96)10031-1) / Trends Biochem. Sci. by M Rechsteiner (1996)
  45. Takeuchi, O. et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164, 554–557 (2000). (10.4049/jimmunol.164.2.554) / J. Immunol. by O Takeuchi (2000)
  46. Hemmi, H. et al. Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000). (10.1038/35047123) / Nature by H Hemmi (2000)
  47. Sato, S. et al. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int. Immunol. 14, 783–791 (2002). (10.1093/intimm/dxf046) / Int. Immunol. by S Sato (2002)
  48. Barton, G.M., Kagan, J.C. & Medzhitov, R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7, 49–56 (2006). (10.1038/ni1280) / Nat. Immunol. by GM Barton (2006)
Dates
Type When
Created 17 years, 3 months ago (April 27, 2008, 2:50 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 7:35 p.m.)
Indexed 2 days ago (Aug. 20, 2025, 8:38 a.m.)
Issued 17 years, 3 months ago (April 27, 2008)
Published 17 years, 3 months ago (April 27, 2008)
Published Online 17 years, 3 months ago (April 27, 2008)
Published Print 17 years, 2 months ago (June 1, 2008)
Funders 0

None

@article{Kawagoe_2008, title={Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2}, volume={9}, ISSN={1529-2916}, url={http://dx.doi.org/10.1038/ni.1606}, DOI={10.1038/ni.1606}, number={6}, journal={Nature Immunology}, publisher={Springer Science and Business Media LLC}, author={Kawagoe, Tatsukata and Sato, Shintaro and Matsushita, Kazufumi and Kato, Hiroki and Matsui, Kosuke and Kumagai, Yutaro and Saitoh, Tatsuya and Kawai, Taro and Takeuchi, Osamu and Akira, Shizuo}, year={2008}, month=apr, pages={684–691} }